The secondary outcome association between the baseline PD-L1 tumor and immune cell scoring and 2-year DFS was explored using Spearman’s rank correlation coefficient and no statistically significant correlation between the baseline PD-L1 status and DFS was found (p = 0.178 for tumor scoring, p = 0.372 for immune cell scoring). Here, CD274 is linked to neoplasm.